Prevalence of Sleep Disordered Breathing in a Lung Cancer Screening Cohort

Lung Cancer Clinical Trial

— SAILS  

Official title:

Prevalence of Sleep Apnea in a Lung Cancer Screening Cohort Meeting NLST Criteria

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02687997
• Other study ID #: InsitutoFJD
• Status: Completed
• Phase: N/A
• First received: February 17, 2016
• Last updated: September 7, 2017
• Start date: February 2016
• Est. completion date: July 31, 2017

Study information

• Verified date: September 2017
• Source: Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Prospective study of sleep disordered breathing in a lung cancer screening cohort.

Description:

The proposed study is a prospective single arm study evaluating the prevalence of sleep disordered breathing in a cohort of lung cancer screening patients.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 282
• Est. completion date: July 31, 2017
• Est. primary completion date: July 31, 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 55 Years to 75 Years

Eligibility

Inclusion Criteria:

• Age 55-75.

• > 30 pack years tobacco exposure.

• Enrolled in lung cancer screening program.

Exclusion Criteria:

• Inability or unwillingness to undergo a home sleep study.

Related Conditions & MeSH terms

• COPD
• Emphysema
• Lung Cancer
• Lung Neoplasms
• Sleep Apnea Hypopnea Syndrome
• Sleep Apnea Syndromes
• Sleep Apnea, Obstructive

Intervention

Other:
• poligraphy
Sleep study

Locations

Country	Name	City	State
Spain	Fundacion Jimenez Diaz	Madrid

Sponsors (1)

Lead Sponsor	Collaborator
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Prevalence of sleep apnea		1 year